Strategies to generate highly concentrated HIV-1 vector pseudotypes involvi
ng different envelope (Env) proteins including the vesicular stomatitis vir
us (VSV) G glycoprotein, the Moloney murine leukemia virus (MLV) 4070A amph
otropic Env and the rabies G glycoprotein were established. Virus stocks we
re prepared by transient transfection using standard cell culture media or
serum-free media. Such stocks were concentrated 50- to 300-fold by ultracen
trifugation or by ultrafiltration using Centricon Plus-80 units yielding ti
ters of up to 16 transducing units per milliliter. There was no loss in tit
er with any of the pseudotypes tested. Thus, like lentiviral vectors pseudo
typed with VSV-G, HIV-1-based vectors pseudotyped with the MLV 4070A amphot
ropic Env and the rabies G glycoprotein resist inactivation during concentr
ation. This opens up the possibility to generate highly concentrated HIV-1
vector stocks carrying alternative Env proteins on a large scale.